Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  62,278 results for ""IMMUNOSUPPRESSIVE agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Mycophenolate-induced colitis in a patient with lupus nephritis: a case report and review of the literature.

  • Authors : Alakkas Z; Rheumatology Unit, Internal Medicine Department, King Abdul-Aziz Specialist Hospital, Taif, Saudi Arabia. .; Gari AM

Subjects: Colitis*/Colitis*/Colitis*/chemically induced ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/adverse effects ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/therapeutic use

  • Source: Journal of medical case reports [J Med Case Rep] 2024 May 01; Vol. 18 (1), pp. 229. Date of Electronic Publication: 2024 May 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

Record details

×
Academic Journal

The Effects of Chronic Immunosuppressive Treatment on Morphological Changes in Cardiac Tissue and the Balance between Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitors in the Rat Heart.

  • Authors : Surówka A; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.; Żołnierczuk M

Subjects: Matrix Metalloproteinase 2*/Matrix Metalloproteinase 2*/Matrix Metalloproteinase 2*/metabolism ; Matrix Metalloproteinase 2*/Matrix Metalloproteinase 2*/Matrix Metalloproteinase 2*/genetics ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/pharmacology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 18; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.

  • Authors : Zhang Y; Department of Hematology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.; Li J

Subjects: Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/therapeutic use ; Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/epidemiology

  • Source: Systematic reviews [Syst Rev] 2024 Apr 04; Vol. 13 (1), pp. 101. Date of Electronic Publication: 2024 Apr 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101580575 Publication Model: Electronic Cited Medium: Internet ISSN: 2046-4053

Record details

×
Academic Journal

Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice.

Subjects: Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/therapeutic use ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy ; Antibodies, Monoclonal, Humanized*

  • Source: Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 481-489. Date of Electronic Publication: 2024 Mar 06.Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Infliximab in neurosarcoidosis: a systematic review and meta-analysis.

  • Authors : Chaiyanarm S; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.; Satiraphan P

Subjects: Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/therapeutic use ; Adrenal Cortex Hormones* ; Central Nervous System Diseases* Neurosarcoidosis

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Feb; Vol. 11 (2), pp. 466-476. Date of Electronic Publication: 2023 Dec 12.Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

Record details

×
Academic Journal

Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study.

Subjects: Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/adverse effects ; Kidney Transplantation*; Humans

  • Source: PloS one [PLoS One] 2024 Jan 02; Vol. 19 (1), pp. e0295205. Date of Electronic Publication: 2024 Jan 02 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Emerging therapies and respiratory infections: Focus on the impact of immunosuppressants and immunotherapies.

  • Authors : Patterson CM; Consultant in Respiratory Transplant Medicine, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK. Electronic address: .; Shaw TD

Subjects: Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/therapeutic use ; Respiratory Tract Infections*/Respiratory Tract Infections*/Respiratory Tract Infections*/drug therapy; Humans

  • Source: Clinical medicine (London, England) [Clin Med (Lond)] 2024 Jan; Vol. 24 (1), pp. 100015. Date of Electronic Publication: 2024 Jan 17.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101092853 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.

  • Authors : París-Muñoz A; Department of Immunology and Oncology and NanoBiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), 28049 Madrid, Spain.; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, 28049 Madrid, Spain.

Subjects: Immunosuppressive Agents* ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy; Animals

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 29; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Research progress of ophthalmic preparations of immunosuppressants.

  • Authors : Liu Y; School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China.; Xu H

Subjects: Eye Diseases*/Eye Diseases*/Eye Diseases*/drug therapy ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/pharmacology; Humans

  • Source: Drug delivery [Drug Deliv] 2023 Dec; Vol. 30 (1), pp. 2175925.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464

Record details

×
Academic Journal

Phenotype and disease course differences in monogenic and sporadic childhood lupus.

  • Authors : Al-Mayouf SM; Pediatric Rheumatology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Subjects: Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/therapeutic use ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/genetics

  • Source: Lupus [Lupus] 2023 Nov; Vol. 32 (13), pp. 1548-1554. Date of Electronic Publication: 2023 Oct 25.Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  62,278 results for ""IMMUNOSUPPRESSIVE agents""